Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
D000135:Acid Phosphatase / Q000032:analysis; D000251:Adenosine Triphosphatases / Q000032:analysis; D000818:Animals; D002264:Carboxylic Acids; D004285:Dogs; D004950:Esterases / Q000032:analysis; D005452:Fluoresceins / Q000494:pharmacology* / Q000627:therapeutic use; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008026:Ligation; D008291:Malate Dehydrogenase / Q000032:analysis; D008628:Mercury / Q000494:pharmacology* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy / Q000201:enzymology*; D009941:Organomercury Compounds
D002264:Carboxylic Acids; D005452:Fluoresceins; D007527:Isoenzymes; D009941:Organomercury Compounds; C010604:mercurascan; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D004950:Esterases; D000135:Acid Phosphatase; D000251:Adenosine Triphosphatases; D008628:Mercury